Hey‐Chi Hsu

2.1k citations
32 papers · 1.7k indexed · h-index 20
Topics
Hepatitis B Virus Studies (11 papers)Liver Disease Diagnosis and Treatment (9 papers)Renal Diseases and Glomerulopathies (8 papers)
Partner nations
Taiwan

In The Last Decade

Hey‐Chi Hsu

31 papers receiving 1.6k citations

Peers

Hey‐Chi Hsu
Comparison fields: 5 of 85
  • Hepatology 934
  • Epidemiology 886
  • Molecular Biology 455
  • Oncology 226
  • Cancer Research 205
Replace Peter Gunvén with:
Peter Gunvén Sweden
Kohsaku Sakaguchi Japan
A Alfarano Italy
S. Koi Japan
Marcella Visentini Italy
K-H Meyer zum Büschenfelde Germany
Johannes Ludwig Germany
Wilson M. S. Tsui China
Christopher Siegel United States
J R Goepel United Kingdom
Hey‐Chi Hsu relative to Peter Gunvén Sweden Peter Gunvén's profile →
Citations per field
00.5×2.6×
Peter Gunvén · 1×
Citations per year

Countries citing papers authored by Hey‐Chi Hsu

Since Specialization
Citations

This map shows the geographic impact of Hey‐Chi Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hey‐Chi Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hey‐Chi Hsu more than expected).

Fields of papers citing papers by Hey‐Chi Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hey‐Chi Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hey‐Chi Hsu. The network helps show where Hey‐Chi Hsu may publish in the future.

Co-authorship network of co-authors of Hey‐Chi Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Hey‐Chi Hsu. A scholar is included among the top collaborators of Hey‐Chi Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hey‐Chi Hsu. Hey‐Chi Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 144
2 15
3 95
4 1
5 2
6 13
7
Focal glomerulosclerosis manifested with nephrotic syndrome.
1
8 60
9 89
10 24
11 92
12 54
13 103
14 33
15 64
16 57
17
Systemic Lupus Erythematosus in Childhood
1
18 186
19
Transient Neonatal Pustular Melanosis-A Case Report-
1
20 140

About Hey‐Chi Hsu

Hey‐Chi Hsu is a scholar working on Hepatology, Nephrology and Epidemiology, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Renal Diseases and Glomerulopathies (8 papers). The work is most often cited by research in Hepatology (934 citations), Epidemiology (886 citations) and Cancer Research (205 citations). Hey‐Chi Hsu has collaborated with scholars based in Taiwan. Frequent co-authors include Ding‐Shinn Chen, Mei‐Hwei Chang, Wen‐Fang Cheng, Juei‐Low Sung, Chue‐Shue Lee, Ching‐Yuang Lin, Chin‐Yun Lee, Ming‐Yang Lai, Yung‐Ming Jeng and Hong‐Yuan Hsu. Their work appears in journals such as Gastroenterology, Hepatology and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026